Age and APOEε4 correlate with cognitive improvement after Lecanemab treatment.

Abstract

Background: There have been insufficient data for safety and efficacy of Lecanemab therapy. Our research aimed to determine which character of the patients are associated with efficacy for AD patients treated with Lecanemab.

The paper